Summary
- Elizabeth Warren disclosed 13,000 pharmacies left TRICARE since 2022 and demanded an audit and ban on vertical integration in the 2030 contract.
- David J. Smith (Deputy Director, Defense Health Agency) defended the fixed-fee administrator model, citing 46,000 pharmacies and $6.5 billion in taxpayer savings.
- Elizabeth Warren pressed Adam Kautzner (President, Express Scripts and Evernorth Care Management, Express Scripts) on post-claim reimbursement cuts and alleged spread pricing.
- Tommy Tuberville emphasized readiness and access while Elizabeth Warren condemned conflicts of interest and demanded full contractor transparency and accountability.
- Lawmakers cited the fiscal 2027 defense bill audit mandate as next oversight step before Defense Health Agency renegotiates the pharmacy contract in 2030.
Morning digest
Get hearings like this in your inbox
Transcript
Hearing gives us an opportunity to examine a critical component of military health care, the TRICARE pharmacy program. Our witnesses today have a wide variety of experiences from Policy Oversight of the program, all the way to TRICARE beneficiaries using its services. I wanna thank Doctor David Smith, Doctor Adam Kautzer Kautzner. Is that it? That's pretty good. Uh, Doctor Langsford and Mister Greg uh, Rebo. As someone who's spent decades coaching young men and women to perform at highest level, I understand that success depends on preparation, discipline, and access to the right tools. The same principle applies to our military. We cannot expect service members to maintain peak readiness if they cannot reliably uh access the medications and treatments they need. The TriCare pharmacy program serves millions of active duty service members, retirees and military families. For many beneficiaries, access to prescription medicines or medications is not a matter of convenience, it is essential to managing chronic conditions, recovering from injuries, maintaining health mental health, and ensuring overall fitness for duty. As Congress contends to oversee continues to oversee military health care spending, we must strike the right balance between controlling cost and maintaining access. Savings achieved on paper are not real savings if they result in delayed treatment, reduced readiness, or additional health care costs down the road. I'm particularly interested in how the pharmacy program supports preventive care, injury recovery, behavioral health, and overall force readiness. We should be asking whether beneficiaries can access medications in a timely manner, whether military families and rural communities face unique challenges, and whether the department is using modern tools and data to improve outcomes while managing cost. Also wanna understand how the department is preparing the future challenges, including drug shortages, supply chain uh disruptions and the growing costs associated with specialty medica- medications. Ultimately, our goal should be to straightforward provide America's service members and their families with reliable access to high-quality pharmacy services, while being responsible stewards of taxpayer dollars. I thank our witness for appearing here today and look forward to their testimony. Um, we will have senators coming in and out because we have a lot of committee hearings today, so be patient with us. Uh, but we also have a lot of questions that we on- wanna ask. So, thank you for being here today and now, Senator Wan in her open opening statement.
Uh, thank you, Mister Chairman, and thank you to our witnesses for being with us today. We're here today because the TRICARE pharmacy program lacks meaningful oversight. Since twenty twenty two, thirteen thousand pharmacies have left the TRICARE network. That means that's thirteen thousand local pharmacies that can no longer fill prescriptions for our service members, and four hundred thousand military families have gotta get out there and find a new pharmacy. The consequences of losing access to your local pharmacy can be immeasurable. Think about veterans with complex medical needs who rely on the personalized care of a local pharmacist, someone who will check for drug interactions and package medications to maximize adherence, and comfort a caregiver who is overwhelmed by their responsibilities. It is the kind of care we want for our military families, and it is the kind of care they deserve. I have letters from fifty-eight pharmacists who speak directly to this issue. Mister Chairman, I request that they be entered into the record.
So done.
This subcommittee has a responsibility to understand why this kind of care is shrinking in TRICARE. So we need to look at the contractor who is running this program. Since two thousand three, DOD has awarded the TRICARE pharmacy contract to Express Scripps, the largest pharmacy benefit manager, or PBM, in the country. For twenty-three years, they have had an exclusive contract with the most recent contract worth at least four point three billion dollars in revenues over seven years. So, what does Express Scripps do with billions of taxpayer dollars? Well, they decide which retail pharmacies are in the TRICARE network and what they're gonna get paid for a prescription. They process pharmacy claims and they run a mail-order program through Express Scripps subsidiaries their own subsidiaries called Express Scripps Pharmacy, and Accredo, a specialty pharmacy. Here's the kicker. Express Scripps both decides the reimbursement rates for its competitors and it provides its own pharmacy benefit services all of it gets billed to TRICARE. And that seems to me to be a pretty clear conflict of interest. And yet DOD actually requires the TRICARE pharmacy contractor both to own a PBM and its own pharmacy. I don't know who talked them into that, but it is an open invitation for Express Scripps to milk the federal government, to kick out the competition, and to steer a lot of money its own way. The squeeze plate is not hard to pull off. In a traditional PBM contract, when the same company owns a PBM and a pharmacy, it can leverage the vertical integration through tactics like spread pricing, in which PBMs charge insurers more than what they reimburse pharmacies for um uh for a drug or engage in steering in which they under-reimburse the competitors and send more business to the PBM's own pharmacy. DOD and Express Scripts are quick to clarify that TRICARE pharmacy contract is not a traditional PBM contract. So they claim that these profit maximizing games don't apply to them. The problem is the facts. Audits of Express Scripts and other government contracts show exactly these same practices. But DOD and Express Scripts want you to believe there is nothing to see here. Okay. But if that were true, DOD and Express Scripts should be rushing to provide this committee with proof. And yet for three years now, I have repeatedly asked for the terms of DOD's contract with Express Scripts, only to be told for three years that what DOD pays for prescription drugs is either proprietary or a trade secret. And that people like the chairman and me, whose job it is to conduct oversight on exactly this issue are not allowed to see it. After I pressed Assistant Secretary Keith Bass on the department's weak oversight of this contract during a hearing before this subcommittee in May, he committed to conduct an annual review of the contract and to disclose the differences in reimbursement rates and fees between the retail pharmacies and the Express Scripts subsidiaries. Nearly two months later, I am still waiting for those numbers. If DOD and Express Scripts refuse to share this data, we can draw only one conclusion. The contract that DOD and Express Scripts want us to believe is so different, is not really different at all. Now, I am glad that this committee included a requirement in the fiscal year twenty twenty-seven in DAA. to audit this contract. We need to pass that requirement into law. DOD has also begun negotiating the next pharmacy contract, which will take place in twenty-thirty. I urge DOD to flatly prohibit vertical integration in the next TRICARE pharmacy contract. A vertically integrated PBM has every incentive to line its own pockets, and DOD should not be using taxpayer dollars. to fund these schemes. If DOD wants to use a PBM, then get one that works exclusively for DOD and American taxpayers, and not one that is simultaneously trying to increase profits for its parent insurance company. So, I look forward to discussing these topics. Thank you again for having this hearing, Mister Chairman.
Thank you, Senator Warren. Uh, before we start, the personnel subcommittee has received a number of statements for record. Without objection, they will be included in the record. Now, uh, we have four witnesses. Uh, Doctor Smith, we'll start with you, but I'd I'd like to say this. W We we have a lot of questions.
Yes.
Uh, I I've read some of your opening statements. They're rather long. Please keep your statements short. Now at the end, if you wanna continue with your statement, we'll let you do that. But I'd like to get to the questions because we have senators here that need to, need to get on to other other hearings. So Uh, Dr. Smith, we'll start with you, please.
Well, Chairman Tuberville, Ranking Member Warren, and distinguished members of the committee, thank you for the opportunity to testify before you today, alongside my distinguished colleagues from the private sector. The department is proud to deliver one of the most comprehensive health benefits of any employer in the country, to include an exceptional prescription drug benefit offered through three points of service, the military treatment facility, the TriCare mail-order pharmacy, TMOP, which provides home delivery, and the TriCare retail pharmacy network. My written statement provides much more detail, as you pointed out, sir, um, uh, of the TriCare pharmacy program, addressing our contract support, as well as how the government directly manages the benefit. I will, however, touch on a few important items that I know are among the greatest concerns you have raised with us. Over seventy percent of all prescription medications are provided through either the mail-order or the retail networks, which are managed by the Defense Health Agency through our TriCare pharmacy contractor, Evernorth Federal Services. This contract is different from most civilian models for administering prescription drug benefits. DHA uses a pharmacy benefit administrator or a PBA model rather than a traditional pharmacy benefit manager or PBM model, commonly used by many employers and health insurance firms. The defining feature of the PBA model is that the DHA pays the contractor a fixed administrative fee per prescription, filled at retail or team-up. The Tfarm five contractor cannot generate revenue from price of drugs themselves at either retail or mail-order outlet. The civilian PBM model often controls the formulary placement as another mechanism to drive revenue streams which cannot happen under our contract, due to the government's uniform formulary process. The government provides these functions and generates the savings for the program. We are essentially the PBM for the and saving um dollars for the taxpayer. Through this model, the government ensures contractor incentives are aligned DHA pharmacy program goals rather than revenue generated from drug pricing. The DHA does recover costs on drug prices directly from the pharmacy manufacturers, not the pharmacy contractor, thanks to the statutory authority that Congress has provided us through the TRICARE retail refund program for drugs dispensed at retail. Recovered refunds are returned to the government, and are independent of the T farm five contract. Since the program was first introduced, the department has recognized over twenty-two billion dollars worth of savings, and in fiscal year twenty-six those savings are projected to ra- uh to uh reach two billion dollars. The DHA establishes uh access to pharmacy service requirements as part of the contract. The contractor must offer at least one network pharmacy within a fifteen minute drive for ninety-five percent of all the beneficiaries, and maintains a minimum network size of thirty-five thousand pharmacies. Currently there are over ninety-eight percent of our beneficiaries who are within a fifteen minute drive time, and over ninety-nine percent that are within a thirty minute drive time. The retail network consists of forty-six thousand pharmacies, eleven thousand higher than the contractual floor. The government has full visibility and control over the cost dispensed from our mail-order programs, and the Defense Logistics Agency procures and replenishes through the Prime Vendor program using the established pricing off the federal supply schedules. Evernorth receives no reimbursement for the cost of drugs, themselves dispensed through and under team-up. The government determines the TRICARE pharmacy uniform formulary for the covered drug list through a physician-led Department of Defense, uh, Pharmacy and Therapeutics P and T Committee, and the Department of War P and T Committee develops and recommends drugs for formulary tiers, sets priority prior authorization criteria, and ensures the pharmacy benefit is standardized across all points of service, based on medical needs first and foremost. The government-managed model has saved the taxpayers over six point five billion dollars in FY twenty-five. through federal supply schedule pricing and statutory refunds. In conclusion, the DHA is proud of the comprehensive worldwide pharmacy benefit it offers to our nine point five million beneficiaries, and similar to the overall US health system, pharmaceutical cost growth remains an area of intense focus and concern. The department continues to explore approaches that ensure continued, timely access to hard-earned benefits, in a physically responsible manner. Thank you again for the opportunity to address our approach to the managing this important program, and I appreciate your vital support to the MHS and look forward to answering your questions.
Thank you, Dr. Caster.
Chairman Tuberville, Ranking Member Warren, and members of the subcommittee, thank you for the opportunity to p- to appear before you today. My name is Adam Kotzner. I serve as President of Express Scripps and Ever North Care Management. We are honored to serve more than nine million TriCare beneficiaries on behalf of the Defense Health Agency. Service members, retirees, and military families depend on the TriCare pharmacy program, wherever they live and wherever they serve. Ensuring they have reliable access to the medications they need is a responsibility we take seriously every day. I understand the importance of that responsibility personally. I began my career as a hospital pharmacist. Later, when I was diagnosed with stage four melanoma, I experienced firsthand how access to innovative medicines can save a life. Today, the TRICARE pharmacy program brings together military, retail, specialty, and home delivery pharmacies. It provides beneficiaries with safe, convenient access to medications. It helps the department manage rising drug costs and it maintains forced readiness. Congress established the program to provide consistent coverage to TRICARE beneficiaries. Congress sets the structure of the benefit and determines beneficiary cost sharing. The Defense Health Agency determines what medications are covered and how the program operates. The Defense Logistics Agency purchases medications dispensed through both mail-order and military pharmacies. Our role is straightforward. Execute that design with precision and care. Every day, we are accountable for ensuring patients have reliable access to medicines, that the program operates smoothly, and that taxpayer dollars are spent responsibly. We build the broadest network of retail pharmacies across the country at the best possible value for the government. and we ensure service members can access their medications no matter where they serve. That responsibility matters. Behind every prescription is a service member, a spouse, a child, counting on us, and a taxpayer who expects this program to deliver value. I am proud to report that the program is delivering strong results. TRICARE beneficiaries currently have access to more than forty-six thousand network pharmacies nationwide. This exceeds Defense Health Agency requirements by more than eleven thousand pharmacies. More than ninety-eight percent of beneficiaries live within fifteen minutes of a network pharmacy and more than sixteen thousand independent pharmacies nationwide participate in the network. We continue to welcome any independent pharmacy who wishes to join the TRICARE network. Through the TRICARE mail-order pharmacy, we help insure medications reach service members and their families across the country and around the world. In turn, government pricing generates significant savings for beneficiaries, the department and taxpayers. Collectively, our work helps the department deliver reliable access to medications for TRICARE beneficiaries while controlling costs. This preserves resources for other mission-critical priorities. According to GAO, this is one of only two major TRICARE contracts that has decreased in cost over time. We operate within the framework the government has established and we are committed to continuous improvement as the needs of the military evolve. We welcome the opportunity to discuss how we can continue strengthening service for military families and taxpayers. I look forward to your questions.
Thank you. You you get bonus points for cutting it down pretty good. Thank you. Doctor Lansford.
Chairman Tuberville, Ranking Member Warren, and members of the subcommittee. Thank you for the opportunity to testify before you today. My name is Doctor Michael Lansford. I'm a pharmacist and owner of Roden Smith Pharmacy in Clovis, New Mexico, uh, and sits next to Cannon Air Force Base. It's a community of active duty, uh, members, their dependents, and retirees, and we've been able to serve this community for as long as I can remember. Remember, we did anyways up until twenty twenty three, when Express Scripts forced us out of the TRICARE program. For years, TRICARE beneficiaries could choose the pharmacy that served them best. For most, that was a community pharmacy like mine, that provides a higher level of personal care, easier access, same-day medications, packaging, medsync, immunizations, delivery, compounding, and a pharmacist that knew their family and their situation. Now many pharmacies like mine have been forced out of the TRICARE program. We were pushed out by contract terms that made an already difficult participation impossible, leaving beneficiaries with fewer choices and less access to the care that worked best for them. I reviewed all of the almost seven thousand prescriptions we filled And twenty twenty-two, our y- our last year in the program, and we are - we were reimbursed on average thirty-seven cents below the cost of the drug itself without any additional allowance for overhead. After ESI was awarded the Tfarm five contract, they drastically reduced their reimbursement rates, such that I would have lost almost nine dollars on every prescription I filled before overhead. or for any other expense. That would have been catastrophic for our business's viability and for all the other patients that we serve. Prescription care should not be a loss leader. No pharmacy can continue serving patients under a contract that requires it to lose money on the very care that it provides. ESI's contract had real life consequences and was felt acutely by the families who live and depend on our care locally. People like Lynn, a disabled retired airman, and Jelaine, his wife, and also his full-time caregiver. Before each monthly fill, I worked with Jelaine to reconcile changes, identify concerns, and ensure his medications still made sense. I can't take care of them anymore. Like the many military spouses, holding down the fort at home while their airman is deployed abroad. They used to be able to come through the pharmacy drive-through or pop in for an antibiotic for a child. Now they have to wade through security lines, trying to get on base pharmacy, hoping the drug is in stock when they arrive. Or all the elderly retirees, they used to be able to come in, dump their problems or confusion quite literally on the counter in front of me, in front of somebody they knew and trusted. I can't do that for them anymore. And it wasn't just the patients that suffered under this contract change. I had to look each of them in the eye and say, " I am sorry. I can no longer help you." Mail order may deliver medication. Community pharmacy is where care is delivered. These stories were not inevitable. They were the purposeful result of network terms ESI chose to impose, and the conflicts of interest inherent in the system. ESI decides which pharmacies uh can participate, how much they will be paid, and then profits when the patient is redirected to one of their mail-order or specialty pharmacy facilities. Then ESI supplies most of the data to judge whether or not the network is adequate or if they are successful. No contractor should be allowed to referee a game while also competing in it. Military families experience the consequences while the contractor reports that the system is working just fine. Congress can and should correct this, require an independent audit, measure real pharmacy access, require transparent and sustainable reimbursement, protect patient choice, and establish conflict of interest safeguards that require a non-vertically integrated manager. The question is not what pharmacy or what military families can tolerate, it's what they deserve. Thank you.
Thank you. Mister Raybold.
Thank you, Chairman Tuberville, uh, Ranking Member Warren, and, uh, distinguished members of the committee. My name is Greg Reibold. My name is Greg Reibold, uh, and I'm with American Pharmacy Cooperative, consisting of approximately fifteen hundred independent pharmacies throughout this country. Um. Grateful for the opportunity to speak, more grateful that uh Doctor Lansford here had the opportunity to share his experience which matches the experience of thousands and thousands of independent pharmacies across the state I I would lead with this I would posit that what Express Scripts did in the TriCare retail network is the poster child for while P for while PBMs should not be allowed to own pharmacies. Mail-order pharmacies, or retail pharmacies. It speaks to the problems of vertical integration. Now here's the thing. The law is complicated. Uh, under current law, TRICARE, federal law, absolutely favors mail-order pharmacies. It's entrenched. It restricts retail pharmacies from filling certain brand-name maintenance medications. And it, in the statute, penalizes beneficiaries for choosing retail via higher cost sharing on paper. And every chance Express Scripps gets Every chance they get, they love to tout the savings of mail-order pharmacy. But here's the thing. Under DHA's own data, it turns out that despite the federal code, over and over and over again, it's cheaper for a TRICARE family, for a TRICARE beneficiary to fill a prescription at a retail pharmacy, than it actually is at ESI's mail-order pharmacy. It's cheaper on those cost shares, stunningly filling a generic medication at a retail pharmacy in TRICARE, not only is cheaper for the beneficiaries, via lower cost sharing, it's cheaper for the agency itself. According to their own reports, year over year over year, generic medications on average are cheaper at retail pharmacies than at Express Scripps mail-order pharmacy. In twenty eighteen they were cheaper by eighty-five percent on average for a thirty-day generic medication. And so what happens? prescripts in around twenty twenty two, wanna cull between thirteen and fifteen thousand retail pharmacies from their network under the auspices of cost saving, I would posit, and if you're anything like me, and I know I am, I would posit that that you look at their self-interest. You look at the vertical integration. And DHA's own data shows that between twenty eighteen and twenty twenty two, ESI's mail-order pharmacy and the TRICARE network lost about nine percent of utilization. Nine percent utilization. Beneficiaries were choosing retail pharmacies to get the care that they deserve. And so what does Express Scripps, the PBM, do? They cull around thirteen thousand retail pharmacies from their network. Right? I think the GAO figure was, was around potentially three hundred and eighty beneficiaries that lost access to their pharmacy of choice. But you know who wins? Express Scripps Mail Order Pharmacy, the pharmacy owned by Express Scripps. That's the only winner here. The only winner here, and I wanna talk a little bit more about the Retail Pharmacy Network and I'll be quick, but Express Scripps loves to say, Doctor Acosta said, right, this program is different, there's nothing to see here, we operate differently. First of all, in federal pleadings, Express Scripps doesn't call themselves a PBA for TRICARE, they call themselves a PBM. Additionally, in court filings Express Scripps has said that they manage the TRICARE Retail Pharmacy Network in a manner that's indivisible, and indistinguishable from their other networks, including the Federal Employee Health Plan. That's Express Scripts' words. In court filings, there's no difference with how they manage that program. That's stunning and it's damning. And the reason it's stunning and it's damning is because the Office of Inspector General for the Office of Personnel Management has looked at Express Scripts' practices in their retail network for two Federal Employee Health plans. You know what they found? They found the books didn't match. They found that the drug prices they were reporting to the federal employee health plan clients didn't match the lower reimbursements they were negotiating with retail pharmacies, to the tune of eighteen million dollars. That tells you two things. One, they got two sets of books, and two, spread pricing is alive and well in the Express GRIPS retail TRICARE pharmacy network. I think the good news is there's things that we can do. Absolutely immediately I think DHA should engage in an audit using their Office of Inspector General with an inter-agency agreement with the Office of Personnel Management's Office of Inspector General. They've looked under the hood and they know where those bodies are buried. On top of that, I think certainly the contract can be improved to prohibit vertical integration, and to close these loopholes. And lastly, legislation is absolutely in order to remove the entrenched favoritism towards mail-order pharmacy, increased patient choice, end PBM steering, and take away the ability of Express Scripts to manipulate drug prices by moving to a market-based index. Thank you, Chairman.
Thank you very much. So obviously we have some disagreements in here. Let's get those out and and see if we can make it better. I'm, for six years I'm on the Health Committee and I've heard a lot about this, uh, over the years. So, uh, this'll be good. And, uh, I'm gonna yield my time to probably a guy who knows more about health care. Anybody up here is a being a senator guy. and the healthcare business for a long time, Senator Scott.
Thank you, Chairman. So, um, my background is I had two hundred and eighty-five thousand employees and I used PBM. I also owned at one time when I was running a hospital company, uh, the third biggest PBM. And then I was, um, the, the, I think the largest shareholder in a pharmacy chain that went through all the struggles of trying to make money, uh, where move things were moved into mail order, not just, not just drugs, but everything was moving to metal ordering so you, you know, you're losing more, so everybody up here, I've, I've sort of been in, in your position, so Doctor Smith, before I get, before I get to the PBM part, can I just ask you a um pretty simple question? How many uh fighter jets do we, does America buy from China? You know of any? You ever heard of any warships?
Not aware of any, but I mean, yeah.
And we w- it seems like a pretty stupid idea to buy, buy from them, wouldn't it, because they're they're we're building military because they're our adversary right
yes sir
so but the same time we buy drugs for them everyday and it's my understanding that that you know that we part of the reason we don't buy uh fighter jets or warships is from china is because one the um we don't wanna be relying on them and uh we probably could save some money right probably we might do it cheaper so why are we continuing to buy chinese drugs uh when we don't wanna rely on them for fighter jets or anything else
so sir i'm um we are well aware of some of the dependencies that are in the system that um we've had this discussion with a number of you the national security uh concerns that we have um and i believe we try to only buy t a a compliant um drugs which is part of the reason for the difference in the generic pricing um depending on where you are for the venue Uh, but we are doing a number of different efforts to try to shore up that chain. Um, and in um, next year, um, in that president's budget you will see um, funding that is dedicated to trying to do a number of efforts relative to um, shoring up that supply chain.
So, n- Dr. Smith, your part of your job is you wanna make sure that every um, buddy that's relying on TRICARE can get the drugs they need,
That's right.
right? and you wanna get the best price you can because it's tax payer money right
absolutely
that's you're trying to do both of those so under the under the uh contract with express grips or evernorth whatever it is so so how are they paid are they uh do they get do they have a profit uh incentive or do they have uh were they making money off the drugs or do they get a set fee and you set the price of the drugs
so the the basic way it works with um Uh, it it's complicated cuz there's there's three different pieces to this, but um relative to the mail-order pharmacy, they get a basically a fill fee from us.
Good.
All of the drugs are bought by the Defense Logistics Agency using the federal pricing and um our negotiations directly with the manufacturers and so we rep- we replace in kind anything that's used by their mail-order pharmacy and then they get an administrative On the retail side, we rely on the network that they built both for the commercial business and also for our business. Um and they have provided in the contract a network um uh discount guarantee for us. If they do better than that, there's incentives for them, if they do less than that, then they um basically have to make up the difference. Then we are the ones that go out and get the refunds based on the TriCare um uh the exact name is the TriCare Retail Refund Program that you all authorized us and we have that, so that brings it back down to about federal supply. And then our our pharmacy and therapeutics committee also then works with manufacturers on volume discounts and all, and we will go after additional discounts to save money. But none of that, and this is a distinct difference with all of the other plans including the FEHPP plans that were referred to um it does not go through evernorth it comes directly and from us back and forth with
So you're you're
and and evernorth actually one more thing sir i'm sorry to interrupt um on the team on the um retail network they are using direct government funds to actually pay the bills to the pharmacies
ok Do you set, so you set the, you decide the price, you're buying the drugs,
Yes, sir.
so it's your drug. And your, and do you set the co-pay, what is for, for Tri-Care?
Um, that's set by you, the, the Congress.
Right, so then, so um, so the um, uh, Express, Express Scripts is not set in the co-pay.
No, sir, they do not. Now, the, the pricing within the network that is paid to the pharmacy is part of, um, Evernor's work. we then come back and get um uh refunds from the pharmaceutical companies if that for the price that is above the FS uh just to be clear on that.
Right and you use you use whether it's Express Expressups or somebody else's use mail order because it's cheaper, right?
Um we use uh the advantage of mail order is multifold one is is that it's uh convenient for the uh person that needs to get their uh their drug on a recurrent basis Uh, but we also buy all the drugs for mail-order. So that makes it significantly cheaper than what is, um, what it costs in the retail network.
OK. So is the consumer mandated to use the mail-order?
If they're, um, for brand name drugs, they are after two fills in the, uh, retail network, we ask them to move over to the, uh, to the Tmop.
And that's a decision you made because you can save money.
Yes, sir.
OK. Alright. And so, um, Doctor Kossner, how m- how many pharmacies are there in the country?
Uh, Senator, there are over sixty thousand retail pharmacies in the country.
And so how many and how many do you contract with on behalf of the Department of Work?
Uh, so we contract today over forty-six thousand, so eleven thousand more than the minimum that's met in the contract.
So when there's somebody like Dr. Dr. Lanceford that l- he loses the contract, what's the right, what's the typical thing, why do, why does that happen, why do, why does the Express Scripts or Evernorth whatever change?
So we have uh sixteen thou- sixteen thousand plus independent pharmacies that that do participate and have chosen to to serve as TRICARE beneficiaries in in our network today uh we we do go out and and and contract, we wanna have as many pharmacies in our network as we possibly can, we would like to have uh even broader network than what we already have. But we do cover over ninety-eight percent of beneficiaries within a fifteen minute drive time today and which exceeds the the the standard within the contract. Um it depends on where those pharmacies are located, certainly those that are in very rural areas. Uh we we may contract with them even even differently because there's an unmet need and a gap that we need to fill. So it really depends on the location of that pharmacy and how many other pharmacies are around it uh that a beneficiary will have access to.
Can I ask one more question? So
All right, one more.
so, Dr. Smith, so if you if you didn't work with Express Scripts on their mail order, you could you could you could contract with somebody else, right? You could contract with another um PBM com company, right? There's no reason you have to do it with their Express Scripts.
Um Relative to the mail order, yes sir. It's a competitively bid contract each time.
OK, thanks.
Thanks, sir Scott. Senator Gorman.
Thank you, Mister Chairman. So, we know that insurance companies often contract with the pharmacy benefit manager to manage the prescription drug coverage. And at least in theory, the way it was supposed to work is that the PBM would work for the insurance company and for the people who have insurance with them. But PBMs have gotten caught doing all kinds of self-dealing. We've already mentioned several times today, it was in in much of your testimony, spread pricing. And that's when the PBM reimburses an independent pharmacy, not its own subsidiary, but an independent pharmacy, seventy dollars for a drug, then bills the insurance company a hundred dollars for the drug, and then, often secretly, pockets the thirty dollar difference. That's spread pricing that we're talking about today. Now, DOD and Express Scripts say The TRICARE pharmacy contract is not a traditional PBM contract. It's a quote " purely administrative contract." They claim that Express Scripts follows DOD directions and passes all of the savings through to DOD, meaning there is no spread here. What you pay goes straight on through and that's how we protect the taxpayer. I taught contract law for many, many years. So what I wanna see is not how DOD summarizes this contract, or how the PBM summarizes this contract. I wanna see what the contract itself actually says. I wanted to see it, but DOD refuses to release the contract with Express Scripts. However, I have a copy of the contract that Express Scripts told the pharmacies that they would have to sign in twenty twenty two or they couldn't get any reimbursement and be a part of the system. And so you wanna be part of TRICARE, you had to sign this. So I just wanna take a look at one of those terms. Section three point five states that Express Scripts maintains the right to quote "aggregate reimbursement, reconciliation and offset methodology". Doctor Kotzner, you're the President of Express Scripts, so tell us, Does this mean that Express Scripts can adjust what they pay pharmacies after a claim has been processed?
Uh, appreciate the question, Senator. Uh, that's, uh, I haven't reviewed that, that document, and so that's a piece I would have to, to take back and evaluate to be able to give you a, a comprehensive answer on. If, if you're referring to, uh, things like clawbacks, we, we don't engage in,
I'm
in clawbacks.
I'm referring to ex exactly what the contract is that your company Express Scripts required pharmacies to sign if they wanted to be part of the network. And I'm just asking, does that mean after you've told the DOD, for example, and my example, that it was a hundred dollar prescription, that you can readjust that price with the pharmacy after the fact, say, down to seventy dollars, just sticking with the same example. Is that what that phrase means?
Senator, as as we we've we we've covered today, the the contract is a full pass through contract with
Well, that's what I'm trying to look at.
DHA.
I'm just looking at the language of what you tell the independent pharmacies who show up. Tell you what, let's ask a lawyer what it means. Uh, mister Reibold,
No, I'm serious.
you've been dealing with these contracts for a long time. Um, Express Scripts is supposed to reimburse the pharmacy at a predetermined price, a hundred dollars in my example. Is that what this contract language says?
Yeah, thank you, Senator Warren. Um, i- i- if I heard you correctly, you said that that contract language references aggregate reimbursement reconciliation an offset methodology. And wha- what I would say is that is, in about twenty years of practicing law, that might be the biggest smoking gun document I've seen in a hearing, right? Because what that means is they get to do post-adjudication offsets. So what they reimburse a pharmacy at the point of sale, they get to move it around. And with all due respect to Dr. Costner, you know, my understanding is for years he was over retail pharmacy networks, so this term shouldn't be a real surprise to him. But what I would say is this, when you take that provision, which gives them the right to move money around after the fact across plans, it's essentially we're talking about what? A complex shell game. We're talking about a Fortune twenty company playing a shell game that you see on the street corner in any city. And you combine that with the fact that in their own court admissions, they admit that they administer their retail network in a manner that's indistinguishable and indivisible from their other networks. And we know the OIG found in quote " pass through contracts and federal employee health plans" the spread pricing was there.
All right. So let's follow through on that because the contract shows that Express Scripts can do spread pricing in TRICARE, notwithstanding what DOD keeps telling us, it's right there in the contract. It turns out that Express Scripts has been caught doing exactly that in other government contracts. An Inspector General audit of the Federal Employee Health Benefit Compass Rose plan found that Express Scripts overcharged the government millions of dollars by failing to pass through all retail pharmacy discounts. And another inspector general audit of the American Postal Workers Union health plan found millions more in unallowable spread pricing. In other words, they've already been caught with their ca- hand in the cookie jar on this. But still, DOD claims that for TRICARE quote, all savings, meaning the difference between a hundred dollars and seventy dollars that you're getting, Doctor Langsford, go directly back to the government. to DOD. So, Doctor Costner, when Express Scripts exercises section three point five and retroactively reimburses uh retro uh and and uh retroactively lowers the reimbursement rates, are you contractually bound to pass that money through back to the DOD?
Appreciate the question, Senator. Our focus is administering the the contract with DHA. It's a hundred percent pass through a rate that we
So your pass is it your testimony today that when you tell Doctor Lansford that he is only gonna get seventy dollars and you've already told the DOD that it cost a hundred dollars, you get thirty dollars back from Doctor Lansford, a hundred and then thirty back. Are you telling us that every penny of that gets sent back to DOD? Is that your testimony today?
Senator, we we don't engage in spread pricing. This is a different type of contract with DHA.
That is a description of spread pricing. If you engage in no spread pricing, then you have a really easy one-word answer here. And that is that you are returning every penny when you retroactively adjust prices. Is that your testimony today?
Senator, this is a pass through arrangement contract and all savings goes back to
Is that your testimony today?
This is a pass-through arrangement contract and all savings goes back to DHA.
Well, if it is a pass alright, let's do it the other way then. If this is a pass-through arrangement would you support an independent public audit to verify that you are complying with full pass-through?
Our we're honored to be able to serve the the TRICARE beneficiaries
Yeah.
and the the government's business is is very important to us. And uh,
So I take it that's a yes?
we we wouldn't ge- we we're happy to comply that
You would support an independent audit to verify that every penny is going back to the government. Is that right? And that you're not using this clause in the contract. Is that right?
If Congress and DHA, I would like to do those those
I would like to do it. We are the oversight committee here. I'm I'm the member of Congress. This is my job, oversight. Will you agree to an audit?
Our our company will comply with what Congress and DHA does deem that we need to do.
So if we make then you will. You know, look, DOD and Express Scripts say there's no spread pricing in the TRICARE contract, but the same language that Express Scripts used to built other government plans out of millions of dollars is also present in TRICARE. We may well find that Express Scripts is playing the same games in TRICARE or not, But we can't tell without an independent audit. I am glad that we have a provision in this year's NDAA that will require an audit here. But frankly, I'm pretty outraged that you drag in billions of dollars from taxpayers and that you won't submit to an audit when it's clear that you have the opportunity to bilk the federal government and you have used that opportunity in other circumstances. So, yeah. Thank you, Mr. Chairman. I appreciate the extra time.
Thank you very much. Um, Dr. Langford, as a pharmacist who previously participated in Tracare Network and then made the decision to leave, can you walk us through the factors that led to that decision, specifically what challenges did you face regarding reimbursement, rates, administrative requirements, and other aspects of the program, and what changes would be necessary for your pharmacy or others like it to rejoin the network?
Thank you for the question, uh, Senator. The direction of the industry has been unsustainable for a long time. Uh, PBMs, uh, and their vertically integrated organizations, um, take every opportunity to, to underpay and compromise the, the local health care networks that already are in place and exist. In this particular instance, it would have become the worst contract that we would have been a part of, uh, only second to New Mexico Medicaid at the time, which later went on to recognize the problem with about half of the, the rural pharmacies in the state closing over a short time frame, and they passed legislation fixing it, uh, a NADAC plus model that supports pharmacies staying in business.
Very good. Um, Mister Raybo, of from the perspective of the independent pharmacy community, what are the most significant challenges pharmacies faces in participating in TriCare network today and how have those challenges affected beneficiary access to pharmacy services?
Yeah, thank you for the question, Mr. Chairman. And, you know, what what I would say is, and and just to follow up when I said earlier, is, you know, when you have vertically integrated, when you have the PBM that also owns the mail-order pharmacy, and Just to set the record straight here, what happened is Express Scripps went to DHA in late twenty twenty-two, and they asked to reduce the pharmacy network by up to fifteen thousand. They got that permission and they wielded underwater reimbursements as a sword. They wielded underwater reimbursements to purge roughly thirteen thousand retail pharmacies from their network, thirteen thousand competitors. On the heels, on the heels of, in fact, them losing nine percent utilization at their mail-order pharmacies between that twenty eighteen and twenty twenty two. So, you know, that I I think that in and of itself is is damning. And and the other thing that I think is is just so so important to understand here is when you have these vertically integrated pharmacies and they're and they're engaging in these practices that favor their mail-order pharmacy it's so tricky because the statutory code says and bear with me here really I'll I'll be fast, but the statutory code essentially says, hey, if if you wanna use a a mail-order pharmacy, you're gonna pay a fourteen dollar copay. If you wanna use a retail pharmacy, you're gonna pay a sixteen dollar copay for thirty days times three. And so in the code, it looks like using a retail pharmacy is over two hundred percent more than using a mail-order pharmacy. But in practice, here's what ESI is doing. They're reimbursing their mail-order pharmacy over and over and over again at the statutory ceiling of fourteen dollars. But they're re- reimbursing retail pharmacies sometimes as low as sixty-five cents a prescription. And so Express Scripps is telling beneficiaries, hey, mail order is cheaper, mail order is cheaper. But when you look at their data, their mail order pharmacy can be as much as sometimes five hundred, six hundred, even a thousand percent more. So they love to tout the savings of mail order, but the way they have implemented this system, ESI is not giving the best.
Senator King. Thank you.
Thank you, Mr. Chairman. I I appreciate your uh allowing a non-member of the subcommittee, but a member of the committee to join you today. Um You'll have to pardon me because this doesn't make sense. Mister Smith, what's the purpose of the contract with ESI? What's the what's the what what does the contract do?
So
What are you buying?
Yes, sir. So the contract is basically a pharmacy pharmacy benefits administrator so what they do is they help us with
that's all
um uh providing the retail network they also provide our mail-order pharmacy um they do the actual mailing
you say your mail-order pharmacy is it yours is it the government's mail-order pharmacy
it it is yes sir we're the ones that contracted for it so i think it's reasonable to say it's run by
but i thought i thought this company owned the mail-order pharmacy
efs Well, they own the mechanism for the mail-order pharmacy.
What does that mean?
We tell them how to run the mail-
Do they own it or not?
Sir
Is it the mail-order pharmacy one of your lines of business, Mr. Dr. Kozner?
Senator, the the government buys the drugs
Got it.
through a a replenishment model. We just do the physical dispensing of those within our facility, and we're paid a flat fee to do that.
You're paid a fee per prescription.
We're, yeah, we're paid a a fee,
I
one, to adjudicate the prescription, so we adjudicate over two hundred million prescriptions a year. For that we are paid a flat fee and we do nearly eighteen thousand safety, quality, benefit checks on every prescription.
But I I don't
Additionally
But but you also have these independent pharmacies. What I'm puzzling where here is you've got somebody who you're hiring to manage the distribution of drugs. who also is in the drug distribution business. And it's see- there's an inherent conflict of interest there, it seems to me. I just don't I'm a I'm a country lawyer from Brunswick, Maine, but I don't get I don't get this arrangement.
Sir, they're um they don't own retail pharmacies other than
No, but they own the f- they own the the uh the mail order. Why wouldn't they in every case do whatever they could to move people toward their business as opposed to these independent pharmacies? Right?
In general, we are trying to move them to mail order because for us it is a cheaper venue. Um and uh our our goal is to
Is there data that in the
make sure the beneficiaries actu
the data that validates what you just said, that the uh a drug X to beneficiary Y is cheaper if it comes by mail order versus from a independent pharmacy?
Yes sir, because of some of the restrictions that other mail order pharmacies don't have to have, that aren't serving us, for example, TAA compliance, that means often they can buy much cheaper Chinese generics and other things. Um, so when you do on a drug by drug comparison you will clearly find there are places where we pay a little bit more.
Yeah, and I I I don't understand hiring somebody to manage the
But we s-
drug distribution that also has a drug distribution arm of their own company. Am I am I missing something here?
You're going.
But we are the ones that actually provide the drug. to them for the mail-order pharmacy,
I don't see, if you're if you're
so the drug distribution is not relevant here. We are providing the drugs and then they are simply packaging it and sending it to the beneficiary.
But they also manage this network of independent pharmacies.
It's a there's a
I mean, again, they have they have an they're running they got business X over here and fifteen thousand business Ys over here, why wouldn't they always try to steer all the business to the one that they get a fourteen dollar fee every time? Why? I mean, again, this this contractual arrangement makes no sense.
The the one that Sir, it is very complex, but the mail order, it the fourteen dollar fee is the mailing, et cetera. That is not what it costs on the retail side. The we ha- the copays are set with Congress. Um, it is a, we have a higher price on the retail side, um, because it costs ultimately more for us Because we are not supplying the drug at the price that we can supply it to your father.
Let me out here, Mr. Rehbold. Am I am I just crazy or
Yeah, thank you, Senator. And I I'd respectfully disagree with, uh, DHA's data frankly, right? Because in your annual reports you note that generic medications are cheaper year over year at retail pharmacies than they are at the mail-order pharmacy, in twenty eighteen by as much as eighty-five percent. You also note that your theory on why beneficiaries continue to choose retail pharmacies over Express Scripps mail-order pharmacy is because Express Scripps uses a lesser of logic. And what that means is they are setting the copay for beneficiaries at fourteen dollars at their mail-order pharmacy when it may cost a beneficiary as low as sixty-five cents at a retail pharmacy.
Well, let me
So I absolutely dispute the notion that for generic medications, it's cheaper at ESI mail-order, your own data disputes that.
Let me, let let me, let me change the
And of course that's where it has to be apples to apples, and I was not saying generics exclusively, which is what you've been concentrating on.
Alright, let me let me change the subject a bit. Um, access, concern, I'm I I'm from a very rural state. We've got something like forty-five percent of the people in our state are in pharmacy deserts. And uh, that's a real problem. Apparently, uh, my understanding is DHA does not audit the information about access and and uh that's provided uh by the by the company. Is that true?
No, sir, that is not true. Um, we have had Guidehouse consulting actually do an independent audit of the access numbers that Ever North has been providing us and we have found that they are in compliance with the contract.
And the company you just mentioned is independent of Ever North.
Yes, sir, uh, it's a it's a it's the federal arm originally of P W C.
Uh, f- final concern, well, two two other concerns. One is the differential for reimbursement, I mean, if if by definition the reimbursement is minus nine dollars for an independent pharmacy that's you're that's a model for getting rid of all independent pharmacies um
so sir uh when we've looked at it the natac price is basically about comparable across the um the independence and the what we're doing with the uh the chain the chain drugs uh i can't speak on it's evernorth is the one that that deals with the uh the fill fees um but i'm not sure i understand uh because at least on balance that's um that's what we see in in the data now i will say if there's a fair number of pharmacies in the location then clearly the one with the best pricing is the one that uh potentially ends up being in the network but i can't speak for that that's really ever north in what we rely on them to do for us
I just one final note, I'm concerned about the Coast Guard. We have a series of Coast Guard stations in Maine,
Sure.
they're very remote, access is very is a significant problem and I hope that's something that can be addressed.
Yes sir, we uh we certainly are aware of that um in your great state of Maine, in Wisconsin there's a number of places where they're clearly in deserts both for the healthcare side and the other and we work closely with them. Um I will say our partner has um been very good about when we point out that there's an area where there's clear access issues, um uh trying to work with the pharmacies in the area and um often they end up in the network.
D- does this contract go away for a bit periodically?
But Yes, sir.
How often?
Um the last time was in uh it starti- this one started in twenty-three and the next round will be in twenty-nine.
Thank you. Thank you, Mr. Chairman.
Thanks, Senator Kagan. Without taking any warm-up pitches, I'm gonna throw Senator Smith into the game.
Alrighty. Thank you, Mr. Chairman. Um, um, Admiral Smith, you prefer Admiral or Doctor, by the way? You have Doctor here, but I have
Um,
What do you prefer?
anything works, sir, or Dave works, too.
OK. Well, when I was Attorney General of Missouri people would call me General. I was always very uncomfortable with that, especially when I was around real generals. So I'd Um, anyway, Doctor Smith, um
I am the real Admiral, but
Well, I'm gonna call you Admiral.
Then I retire.
I'm gonna call you Admiral. Admiral, um, I wanna, I just wanted to ask you some, a few questions about um, on the, on the pharmacy side. In your view um, what unique capabilities does the mail-order pharmacy provide um, to the department?
Um, on the mail-order side, it, it provides a convenience to our folks. It does um, uh, provide, you know, we're a worldwide organization. And so they will send to APO and FPO addresses along with um when I deploy, they will adjust the medications for my deployment length so that I make sure that I actually get the drugs that um are required for that um that period of time. So they're - they're very helpful on that side. We also then uh have it set up to where it's just a fill fee and we supply all of the drugs um using um um FSS pricing or better um through DLA.
Uh and it may seem like maybe an obvious question but I think worth asking, and how do you since given the the nature of this committee how do you how do you think that this um uh as a how do you view this as a component of readiness for men and women?
Um I think it's absolutely critical um we talked about the worldwide um distribution of our our our personnel and the fact that um our partners help us with that. Um clearly we have to make sure that we um have that um um uh logistics chain if you will. Additionally um having good access means that I can start the drug sooner and hopefully have a a quicker result to make me more uh fit and deployable sooner or my family recover faster. So having a robust pharmacy benefit is is what we clearly want to have and we but we will also wanna be uh cognizant of the uh pricing in pharmacy and make sure that we're getting the best value for the taxpayer.
Is your assessment that Express Scripts has performed well in that regard? Cuz uh as
Yes, sir.
yeah. Um and uh and how do you how do you measure success? Um as relates to how Express Scripts is doing.
Well, we have a whole number of criterias that we look at, uh everything ranging from claims accuracy to um our customer satisfaction rates and they routinely run um in the nineties per cents um so we think that certainly my impression is is that um uh the contract is great value and for the government
when uh when congress established the the tricare pharmacy benefit um you know it my understanding is it it it envisioned multiple points of service, retail, um, facilities, mail order, all kind of working together. How ha- how have you seen some of the, um, utilization shifts over the years as how people access?
Yeah, it it has waxed and waned, quite frankly, and part of it depends on our MTFs and, um, clearly as you know over time, um, that access has decreased somewhat with our, um, continually, um, uh, uh, rationalizing the system. But um, recently the retail has actually bumped up and I think part of it is the fact that um, the generic pricing um, when we buy the drugs we have to be NDA um, sorry, um, have to be uh uh, trade agreement TAA compliant. And so at times uh, we can't buy the generic that's coming from China or India. Um, and so if I go into a retail network, then I pay whatever that cost is versus the the set um copay. So.
So that flexibility is obviously important
That's right.
cuz people have different ways to to access. Um, ho- how would you assess Express Script's um
That's right.
ability or or or uh capability as they've demonstrated to uh for people to access pharm pharmaceuticals or drugs in a in a flexible way? How would you assess? What have they done that that has impressed you in that way?
Um, first of all it's just the access uh, you know, we went from a a mileage to an actual uh time because i think that's much more realistic as to what it really takes and when you look at um how accessible we are um i think that's that's one of the strongest um criteria that we see uh with with what they're what they have put together for us
well the pitch clock is run down mister chairman um but i wanna thank you for your For your time, your your testimony, Admiral.
Yes, sir.
I don't know if that stuff is so paid attention.
Let's
That's fair.
It's still my first term. Forgive me.
Thank you, Senator Smith. Senator Blumenthal.
Thank you, uh, Mister Chairman. Uh, Doctor Kousner, um, maybe you can explain, um, when Express Scripts makes formulary decisions, do, uh, the manufacturer rebates have a role?
senator i i appreciate the contract and and this is one area where uh normal p b m operations what we do for employer is very different than what we do here for dha and for tricare beneficiaries so in this instance uh dha makes all clinical decisions on formularies prior authorizations and those types of things So they make all the clinical decisions. They also negotiate all of the drug discounts and and rebates for for those products. So we simply, one, adjudicate the the prescriptions and ensure that there is a high clinical quality and safety on those prescriptions. And then in some cases, if we as we've discussed today, we may dispense, uh, tho- those products through our our Tricameral or pharmacy. And if that is the case, we're paid a flat dispense fee.
So you're you're saying for tricare the formulary decisions are unaffected by the manufacturer rebate
i i'm saying for our for our portion of what we do as the contractor for for tricare uh we aren't involved in in any of those decisions or processes all that's done by dha
do they affect others decision makers the the manufacturer rebates
I in terms of of TRICARE, I I couldn't speak to what what decisions the Defense Logistics Agency and DHA may make around their negotiations with drugs and the preferencing of those drugs. And in this instance we we are simply the the contractor and and we're we're focused on providing broad access providing strong clinical quality and service, and ultimately then value to beneficiaries and taxpayers.
Um, well one reason I ask is that um as you know, finding the right health, mental health medication can sometimes take months or even years. Um, once a patient has found a productive treatment, disrupting it can take, um, can have serious consequences. Then there are concerns that the pharmacy benefit mani managers are changing members' medication regimens. uh, even when their mental health is stable. Have you encountered that concern?
Uh, in - in - in practice I - I - I have encountered, uh, tho- those types of - of concerns and it's a piece that we take very seriously, especially for patients that are on mental health drugs, their stability on those drugs and ensuring that once they get on a drug that works for them because many of those drugs do have unique side effects that once you're able to tolerate those on a product that you're able to stay on the product, be able to refill the drug as you need to uh for for those types of medications. But uh in in these instances around these clinical decisions in uh for the TriCare contract uh those those are left to to DHA to make those decisions, and we carry those out.
Well, let me ask you, Doctor Smith. Does DHA monitor whether formulary changes um or coverage decisions result in disruption or interruption in the mental health care treatment of the patient?
Sure, we uh uh, as you're probably aware, have a pharmacy and therapeutics committee. Um and they meet um periodically to review all the new drugs that come out from FTA, but also um every quarter go through classes of drugs uh to figure out placement within the formulary. Um and we have um uh primary f- uh when there are um similar drugs that have similar effects, Um we we will um choose one to be on the primary formulary, but that doesn't mean that I don't have access to the others with prior authorization and some uh paperwork as a provider that I need to do. So um I think it's fair to say that our beneficiaries have wide access to what what is required from them clinically.
What is the single most important improvement that you could see being made in the health care system right there.
Um, for the overall system, um, clearly uh we are um in a similar situation to the rest of the country, which is um being able to attract and um uh retain our health care staff. And um uh we we clearly have on the civilian side some constraints because of the amount that we can actually pay um and so um but my biggest uh issue is is um is the personnel issues that we're we're competing with everybody else in the country and there's clearly uh substantial man power shortages in in the healthcare industry.
Thank you. Next, Mister Chairman.
Thank you, Senator Blumenthal. I got a question for everybody. Take about a minute each. We'll start with you, Mister Raybo. Uh, what kind of pharmacies, what role can they play in improving medication and helping beneficiaries maintain healthier lifestyles? You got about a minute.
Yeah. Th- thank you, Mister Chairman. You know, retail pharmacies are amongst the most accessible health care providers in in the nation, right? They're, accessible in inner cities, where we can also have pharmacy deserts and they're absolutely some of the most accessible for providers in rural. And I think, you know, there's replete studies that show access to retail pharmacies, improve medication adherence, and improve outcomes. And I think leaning into that and leaning into all of the skill sets that pharmacists have to do, um, j- makes a lot of sense from a policy perspective, and it's gonna improve outcomes, improve medication adherence, and ultimately reduce costs. That said, obviously, I am not a pharmacist and would greatly defer to uh, Do- Dr. Lansford in that regard.
Or deliver.
You know, I I I think that uh, retail pharmacy is special in uh, in this country. In in every state, in every community, it is the most accessible place for people to go and get the the questions that they have answered. Um, and it, we don't, it's an uncompensated component of health care that there's no data there's no data on that happening, but it happens all day all day long every day. Um, and and one thing that I find really compelling, you know, I've overheard that that it ESI is receiving a flat fee for their services on a drug that they do not have to pay for. And I can't help but but ask the question what what that fee and uh maybe I might take that deal instead of Express Scripts if it if it were offered to me.
Dr. Coulson.
Uh, Mister Chairman, we we put uh a great deal of effort into the the clinical side of of the work in in working to help uh tri-care beneficiaries military families and and retirees. And so we would focus on continued focus on adherence and helping patients ensure that they're able to to refill those medications from uh an automatic perspective so I don't have to think about it. they're on the drugs that work for them, those drugs are going to continue to arrive, either from a mail order perspective or from from a retail perspective. One of the things that we've recently done as part of this new contract with with DHA is implemented a clinical insights hub. So with pharmacy being the most utilized benefit, this hub allows us to go and pre-identify patients that have complex conditions where they may have the potential to worsen with those conditions. we can then intervene on that patient's behalf, help them be able to get healthier, and be able to prevent them from progressing with a disease state. It's been a a a nice win for uh the organization to be able to work with DHA, and be able to truly help TRICARE beneficiaries stay healthy, and and prevent uh conditions from getting worse.
Dr. Smith.
Um, I I agree with actually everything that's been said relative to uh um making sure that um, and the pharmacists are critical component of making sure that our beneficiaries are actually educated about the drugs that they have along with obviously um uh their providers. We also um uh work a number of um they're they're key to us working for example um uh antibiotics and making sure that we're putting them on the the right antibiotic to prevent um unnecessary use of broad spectrum antibiotics and um I think everybody's aware that there's a significant national and international problem with multi-drug resistance and so um I think all of that our pharmacy community is actively engaged in and helping us with so
Thank you. Senator Warren.
Um
Thank you, Mister Chairman, so I just want to dig in a little bit more on the comparison between the mail-order pharmacy price for a drug and what a independent pharmacy charges. So, DOD and Express Scripts say repeatedly, it's in all your stuff, that the mail-order program saves money. But DOD actually reported data to Congress on this in fiscal year twenty twenty three. That's the most recent we've got. So, Doctor Smith did filling a Thirty day supply of generic drugs at Express Scripps pharmacy costs DOD on average more or less than filling the same prescription at a retail pharmacy.
Ma'am, I'm actually gonna have to take that one back for the record.
You don't have to, I actually have it.
So
It's the DOD report on this, and the answer is Express Scripps cost twelve and a half percent more than the retail pharmacy, when you put them all together, how on the generic drugs thirty day supply. So I'm gonna dig just a little bit into how that could happen, cuz the way you describe the business model, it shouldn't be able to happen. So where does the money come from that goes to the different parties here? And one is a flat administrative fee. We've been talking about this flat administrative fee on every claim that it's mail-order pharmacies process. And one lawsuit, that's where I gotta look for data, alleges it's seventeen dollars that Express Scripps gets every time they fill a prescription. Let's look at the cost from the perspective of military families. The Tricare website claims military families will save money by using mail, home delivery. And federal law states that for all non-active duty TRICARE beneficiaries, the copay for a generic drug is fourteen dollars with mail order versus sixteen dollars at retail. So I'm sitting there, military member, and I say, " Okay, I g- I get it, it's two dollar difference and the retail pharmacy is more expensive. But let's pause for a minute. Lots of generic drugs cost less than fourteen dollars. So DOD requires Doctor Lansford and all of the other independent pharmacies to use a lesser of requirement. So Doctor Lansford, under a lesser of requirement that's part of your contract with DOD, if a drug costs three dollars, how much do you charge the patient, sixteen dollars or three dollars?
Well, the pharmacy benefit manager would decide that, and in this case it would absolutely be the lesser of three dollars.
That's right. So you only get three bucks, right? If the thing costs three bucks. That is actually the law. That's in your DOD contract. But what about express scripts? Well, I have an explanation of benefits right here that shows that Express Scripts mail-order pharmacies charge TriCare, charge TriCare and the federal government. Oh, I'm sorry, charge beneficiaries the full fourteen dollar copay, even when the cost of the drug is cheaper. So, there's a big difference in what the customer is actually paying on the cheaper drugs. Now, in addition to the customer's copay, we've just done there's a federal government copay, maybe seventeen dollars, that's the best I can tell from the lawsuit, on every prescription filled. So that means a three dollar prescription, that is it costs three dollars, can earn express fees thirty-one dollars, a fourteen dollar copay from the customer, from our service member, and then a seventeen dollar administrative fee from the federal government. Express Scripts is supposed to save money for DOD, but it appears to me, I mean we just worked the example here, and that's what your own data show, is that it costs more. So this raises the question that's really bothering me, and that is, it goes back to what Senator S uh uh Senator Kainway is asking about, and that is why on earth is DOD requiring vertical integration so that the very company that's supposed to be doing the managing also owns this pharmacy that is competing with our independent pharmacies. And in fact, we've got the data charging more, at least in some of the cases, charging both our service members more and charging our federal government more. Do you think, Doctor Smith, that maybe it is time for DOD to revisit this requirement of vertical integration? And in fact, considering saying, no, you only work for the federal government and there is no vertical integration. That is, you do not own your own pharmacy at the same time that you're trying to manage pharmacy claims for the United States government.
Ma'am, the um using the generic example is a little bit problematic, um because the real cost drivers are the brand name drugs and the specialty drugs. um over um I believe it's fifty percent fifty six percent of my costs come from one percent of the prescriptions.
S- look I let me just look I
So I do think that the generic question needs to be looked at. I frankly will have to take for the record to figure out why we don't decrement the cost of the drug part um of the but of course when you're mailing it
I'm I'm sorry, maybe I wasn't clear in my question, Doctor Smith.
Mm-hmm.
No, no, it's my fault. I'm just trying to ask, do you think maybe it's time to revisit whether or not the person or the entity that manages prescription drugs does not also own a competing prescription drug dispensary that competes with every independent pharmacy in America and creates incentives to prefer your own subsidiary over all of the independent pharmacies out there? Do you think it's time maybe just for DOD to rethink that? You're getting ready to renegotiate a contract here.
I think Ma'am, we're always willing to look at um how we can do this better. And certainly we can look at it, but most of what EFS is doing, quite frankly, is how we have set it up and what we've told them to do it and perform it as. So um I I I I think it's reasonable for us to look at it. We clearly will. I I still, because of the way our contract is set up, I don't get the um the uh issue that clearly we need to have more discussion on relative to conflict of interest
yeah
because we're the ones that are driving people to go to the retail all our rule sets say you need to go to retail for brand and specialty because it's dramatically cheaper in uh through mail order than it is via uh the retail network And so and that's why, for example, with Acredo, the specialty provider that is an affiliate of um Cigna that is the owner also of Evernorth we we make um ninety-two percent of those come through us because we buy the drugs rather than the specialty provider. But happy to look at the system and see for our next
Well
contract whether there is a a better way to set it up.
Doctor Smith, let me just say It may be cheaper to do some things by mail. I fully understand that.
Dramatically.
But I do not know why it is that the company that is administering how we're going to get prescription drugs out to our people and how they're gonna get reimbursed for it needs to own the mail-order pharmacy and be in direct competition with every individual pharmacist out there, and have an incentive to drive all of our prescriptions in a way that will maximize profits for this company. If if we're not in alignment on that central question, I I just don't know how we go forward here, but thank you for having this hearing today. We need independent audits and we need to rethink these DOD contracts.
Senator King, you got any other questions?
No, sir, I have.
You sure you look like you got something on your mind over there.
No, no, I mean, what what I'm saying here thinking is, what if these guys um Didn't have the fam- mail-order pharmacy, but they own CVS.
Yeah.
Would it be, would it make sense to have them administering this program for all these other pharmacies around the country, if they also own CVS? I mean, you don't have to define what, I mean, the conflict is obvious, and it seems to me you're, you're basically saying we've got this company and we we're hiring them to help us distribute drugs, but they also have their own distribution. I mean, the, to me, Doctor the, or Admiral, the conflict is obvious. It's just I I mean, I don't I don't wanna we've we've beaten this horse pretty hard, but I don't I don't understand. Uh, again, I'm coming to this as sort of a a novice, but the the the the the model makes no sense. What what if they own what what if they own CVS? Would that be OK? They own CVS and they also deal with all these independent contractors.
Mm-hmm.
At the at the end of the day, frankly what we are most interested in is making sure that our beneficiaries have um, great access and that we are saving the taxpayer money.
I and I applaud you for that. That's exactly what the mission is. The question is does the stru the structure of this contract serve those purposes?
I would I would hope so, sir.
That's the question.
I I I I think I think there's a need to prove that it doesn't.
Okay. I I hope you will. Thank you. Thank you, Mr. Chairman.
All right, we're going to give everybody about a minute closing arguments. Mr. Rabo, we'll start with you.
Yes, thank you, Mr. Chairman. Um, obvi- obviously a lot, a lot to go over here. I would absolutely echo, uh, the points of Senator King and Senator Warren with regard to the vertical integration. It's funny how it always works out to cost beneficiaries more, harms retail pharmacies, but boy, ESI's mail-order pharmacy comes out looking pretty good. The other thing I wanna talk about really quickly, uh, just to record set is federal code absolutely provides that the federal government gets the same discounts whether they're filled a mail-order or whether they're filled at retail, they get those same discounts. And so I I think that's really important to preserve in the record. Mail-order isn't getting better discounts than retail pharmacies. And and again, like that's so important because that gets lost here. Lastly, I wanna
It means the price is the same.
Means the price is the same.
Right.
Right? And so I'd absolutely push back on that. The last thing that I would say, and I'll say it really quickly, is yes, the Department of Defense contract bars, literally bars fees, rebates, discounts specific to processing TRICARE prescriptions. That's what the contract said. It was in a court filing filed by the Ohio Attorney General for anti-competitive practices against Express Scripts. That's what it says. But what we know Express Scripts does is they negotiate aggregate discounts, non-claim specific discounts from drug manufacturers, from pharmacies, administrative fees from pharmacies. They are engaging in aggregate pricing that allows them to continue to capture revenue from what is one of their biggest clients, and that is the federal government and this TRICARE program. They're finding multiple ways to leverage that and to recoup money. Are they negotiating claim-specific discounts? No. But, boy, I'll bet you that if there's a OIG audit, they're gonna absolutely find that money there. And if I were the federal government, if I were DHA, if I were any one of Express Script's commercial clients, I would be running to an auditor, based on what we've seen here today and based on the contract language that you provided. Thank you.
Dr. Lansford.
Chairman Tuberville, thanks again for the opportunity to testify. Um, there's a there's a lot of layers to this, and and something that is just apparent to me um with my colleagues is that we have a strong desire to serve these people. We wanna be there for them, we used to be able to be there for them, and we wanna be there for them again. All all we expect is reasonable uh reimbursement in that process. And whenever I hear uh the Admiral say, well, there's an expense to mailing it, I think there's an expense to the other components of delivering the drug within my pharmacy as well that do not get accounted for in terms that are sent to me. And uh, you know, we just want a fair shake at it. That's all we want. We just want a fair deal to be able to provide service to these members. Thank you.
Thank you. Dr. Crosner. Uh, Mister Chairman, thank you for for the opportunity today. uh to be able to testify i i would uh first point to again our organization is proud to serve the men and women of the military military families and and retirees we get up everyday to insure that we can do that on the two hundred plus million prescriptions that we service for them every single year we've been doing this for over twenty years and hope to do it for many years to come it is a passion of our organization's if we look at the facts Ninety-eight percent of beneficiaries have a pharmacy within fifteen minutes of their home exceeding DHA standards. We focused on service. Ninety plus percent beneficiary satisfaction is high with the TRICARE benefit and the services that we provide. If we look at the savings, we are providing, uh, to date, given this contract, over a hundred and forty million dollars of savings that has gone back to the government for other real defense components that they can re-utilize those those dollars for. This agreement is a hundred percent pass through. We do not retain uh that fourteen dollars that is collected uh at the mail-order pharmacy that goes back to uh DHA. Uh those components again are are are misunderstood. Appreciate the the time today though and behalf on behalf of the over a thousand uh one thousand veterans that work for our company um Proud of the opportunity today to be able to testify and proud of what we do each and every day, getting up to ensure that we take care of our servicemen and women.
Thank you. Dr. Smith,
Uh, Chairman Hub-
or Admiral, Ad- General.
Admiral, sorry.
Yeah.
Secretary Tuberville. Um, Chairman Tuberville and uh, Ranking Member um, Warren, along with uh, Senator King, appreciate the uh, opportunity to uh, testify today. I do think that this is uh, uh, a uh high quality um uh very good contract that we actually are saving significant amounts of money for the taxpayer, but most importantly doing um a remarkably good job in a complicated uh system taking care of our beneficiaries and making sure that they get the um the access and the support for whatever their pharmaceutical needs are. So we appreciate the uh opportunity and um the various questions and um once again thank you for the opportunity.
Thank you. Very complex issue. One day I think even a football coach might be able to understand all of it. I don't know whether I can or not, but it is pretty complex. Uh it just kinda reminds me though of one of my favorite movies, Coup de Handleoucq. What we have here is a failure to communicate in a lot of areas. And uh, a lot of that is a lot in politics and in federal government. But thanks to all of you for being here. And uh, hopefully we got something out of this and maybe we can do it again. And continue to try to work out all the kinks, but we appreciate all of you being here, we really do. Thank you. Thank you very much. Thank you very much. Thank you, Chairman. Thank you, I should remember. We're adjourned.
Morning digest
Start every morning briefed on yesterday’s hearings
A free weekday email covering yesterday’s hearings and transcripts newly unlocked in the archive.



